Section Arrow
Quote
EOLS.NASDAQ
- Evolus
Quotes are at least 15-min delayed:2026/05/13 07:15 EDT
Pre Market
Last
 6.31
-0.19 (-2.92%)
Bid
6.12
Ask
6.52
High 6.55 
Low 6.25 
Volume 12 
Regular Hours (Closed)
Last
 6.5
+0.18 (+2.85%)
Day High 
6.53 
Prev. Close
6.32 
1-M High
6.7 
Volume 
769.08K 
Bid
6.12
Ask
6.52
Day Low
6.18 
Open
6.18 
1-M Low
4.1899 
Market Cap 
416.20M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.85 
20-SMA 5.39 
50-SMA 4.93 
52-W High 10.62 
52-W Low 3.86 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.66/0.40
Enterprise Value
568.67M
Balance Sheet
Book Value Per Share
-0.44
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
297.18M
Operating Revenue Per Share
2.81
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health25.03-4.11-14.10%57.14PE
Pre Market 24.87 -0.16 -0.64%
ZTSZOETIS76.94+0.27+0.35%12.61PE
Pre Market 77.15 +0.21 +0.27%
CPHIChina Pharma Holdings Inc0.8927+0.35855+67.13%-- 
Pre Market 0.8318 -0.0609 -6.82%
VTRSViatris17.17+0.25+1.48%-- 
Pre Market 17.29 +0.12 +0.70%
ELANElanco Animal Health21.43-0.29-1.34%-- 
Pre Market 23.5 +2.07 +9.66%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.